GENERAL PHARMACOLOGICAL PROPERTIES OF THE NEW VASODILATOR FLOSEQUINAN

被引:0
|
作者
IKEZONO, K [1 ]
FUJITA, S [1 ]
UMEZATO, M [1 ]
HOSOKI, E [1 ]
TOBA, Y [1 ]
KUSUNOKI, A [1 ]
SHINTANI, S [1 ]
机构
[1] OTSUKA PHARMACEUT CO LTD,TOKUSHIMA RES INST,TOKUSHIMA,JAPAN
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1992年 / 42-2卷 / 10期
关键词
BTS; 49; 465; CAS; 76568-02-0; FLOSEQUINAN; GENERAL PHARMACOLOGY; VASODILATORS;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pharmacological effects of a new vasodilator, flosequinan (7-fluoro- 1- methyl- 3- (methylsulfinyl)- 4(1H)- quinolone, BTS 49 465, CAS 76568-02-0) on the central nervous system, somatic nervous system, autonomic nervous system and smooth muscle, digestive system and miscellaneous organs were investigated. 1. The central nervous system: Flosequinan inhibited acetic acid-induced writhing at doses of more than 30 mg/kg p.o. and decreased body temperature and tended to decrease spontaneous movement slightly in mice at a dose of 100 mg/kg p.o. However, flosequinan had little effect on hexobarbital-induced hypnosis, reserpine-induced hypothermia and motor coordination and lacked anticonvulsant and analgesic activities in mice. Flosequinan had little effect on general behavior in rats and did not have any effect on spontaneous EEG and EEG arousal response in rabbits. 2. The somatic nervous system: Flosequinan did not cause muscle relaxation in mice and had little effect on neuromuscular transmission in cats. No local anesthetic activity was exhibited through inhibition of the corneal reflex in guinea pigs. 3. The autonomic nervous system and smooth muscle: Flosequinan produced a relaxation of the isolated trachea of guinea pigs at concentrations of more than 3 x 10(-5) mol/l, but its potency was very weak in comparison with that of iso proterenol (isoprenaline). Flosequinan inhibited spontaneous motility of the isolated uterus of pregnant rats at concentrations higher than 10(-4) Mol/l and the motility of the uterus of non-pregnant rats in vivo was inhibited at 30 mg/kg i.v. Flosequinan does not seem to exert any on norepinephrine, serotonin, acetylcholine or histamine. This is supported by the fact that at concentrations of 10(-4) -3 X 10(-3) mol/l non-competitive inhibition was observed with regard of the contractions of the isolated aorta and vas deferens of rats induced by norepinephrine, the contraction of isolated rat stomach induced by serotonin, the contraction of isolated guinea-pig ileum induced by acetylcholine, histamine and barium chloride and the contraction of the isolated uterus of non-pregnant rats induced by oxytocin. However, flosequinan was more potent as a relaxant of vascular than of these other smooth muscles.
引用
收藏
页码:1200 / 1211
页数:12
相关论文
共 50 条
  • [21] PHARMACOLOGICAL EVALUATION OF YC-93, A NEW VASODILATOR, IN HEALTHY VOLUNTEERS
    SEKI, T
    TAKENAKA, T
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1977, 15 (06): : 267 - 274
  • [22] Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative
    Gras, J
    Cardelús, I
    Beleta, J
    Gristwood, RW
    Palacios, JM
    Llenas, J
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2000, 50 (11): : 980 - 986
  • [23] ANTIHYPERTENSIVE AND GENERAL PHARMACOLOGICAL PROPERTIES OF BUDRALAZINE
    CHIBA, T
    SHIBAMURA, S
    TANAKA, M
    YAMASAKI, T
    HASHIMOTO, H
    KUREBAYASHI, Y
    KASAI, Y
    RYOKAWA, Y
    TAMURA, K
    HIROHASHI, M
    AKASHI, A
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (07): : 1080 - 1087
  • [24] PHARMACOLOGICAL STUDIES OF PENFLURIDOL .2. GENERAL PHARMACOLOGICAL PROPERTIES
    ITO, K
    NURIMOTO, S
    OCHIAI, T
    HORIUCHI, M
    SUZUKI, S
    KUDO, Y
    ISHIDA, R
    KOWA, Y
    FOLIA PHARMACOLOGICA JAPONICA, 1976, 72 (05) : 501 - 517
  • [25] General pharmacological properties of YJA20379-2, a new antiulcer agent
    Eun Bang Lee
    Sung Ig Cho
    Seon Ah Cheon
    Man Sik Chang
    Kyu Bong Kim
    Tae Wook Woo
    Young Kuk Chung
    Archives of Pharmacal Research, 2000, 23 : 72 - 78
  • [26] General pharmacological properties of YJA20379-2, a new antiulcer agent
    Lee, EB
    Cho, SI
    Cheon, SA
    Chang, MS
    Kim, KB
    Woo, TW
    Chung, YK
    ARCHIVES OF PHARMACAL RESEARCH, 2000, 23 (01) : 72 - 78
  • [27] FLOSEQUINAN IN CHRONIC HEART-FAILURE - SYSTEMIC AND CORONARY HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF A NEW LONG-ACTING ORAL VASODILATOR
    DEMARCO, T
    LIU, M
    WOLFE, C
    CHATTERJEE, K
    CIRCULATION, 1987, 76 (04) : 444 - 444
  • [28] STUDIES OF DEPENDENCE OF PHARMACOLOGICAL ACTIVITY OF SOME NEW PYRIMIDINE COMPOUNDS ON THEIR STRUCTURE .1. GENERAL PHARMACOLOGICAL PROPERTIES
    OLEDZKA, K
    ACTA POLONIAE PHARMACEUTICA, 1979, 36 (01): : 95 - 102
  • [29] DISSOCIATION OF THE SYSTEMIC AND REGIONAL VASCULAR-RESPONSES TO THE VASODILATOR DRUG, FLOSEQUINAN, IN HEART-FAILURE
    GOTTLIEB, SS
    HALPERIN, JL
    KESSLER, PD
    ROTHLAUF, E
    PACKER, M
    CIRCULATION, 1987, 76 (04) : 445 - 445
  • [30] GENERAL PHARMACOLOGY OF FENOXEDIL (ANP 3548), NEW CEREBRAL VASODILATOR
    BESSIN, P
    GILLARDIN, JM
    THUILLIER, J
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1975, 10 (03) : 291 - 296